Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 2
2012 3
2014 2
2017 1
2018 2
2019 2
2020 5
2021 2
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Hepatic haemangioendothelioma: A proteiform disease.
Gigante E, Lai Q, Lerut JP, Nault JC. Gigante E, et al. Dig Liver Dis. 2020 Sep;52(9):1039-1040. doi: 10.1016/j.dld.2020.05.041. Epub 2020 Jun 15. Dig Liver Dis. 2020. PMID: 32553702 No abstract available.
Recent advances in liver stem cell therapy.
Kisseleva T, Gigante E, Brenner DA. Kisseleva T, et al. Among authors: gigante e. Curr Opin Gastroenterol. 2010 Jul;26(4):395-402. doi: 10.1097/MOG.0b013e32833a6bec. Curr Opin Gastroenterol. 2010. PMID: 20495456 Review.
Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: A multicentric retrospective study.
Gigante E, Bouattour M, Bedoya JU, Regnault H, Ziol M, Assenat E, Paradis V, Calderaro J, Ganne-Carrié N, Bouhier-Leporrier K, Amaddeo G, Nault JC. Gigante E, et al. United European Gastroenterol J. 2023 Dec 7. doi: 10.1002/ueg2.12503. Online ahead of print. United European Gastroenterol J. 2023. PMID: 38059651 Free article.
Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures.
Bissonnette J, Riescher-Tuczkiewicz A, Gigante E, Bourdin C, Boudaoud L, Soliman H, Durand F, Ronot M, Valla D, Vilgrain V, de Raucourt E, Rautou PE. Bissonnette J, et al. Among authors: gigante e. J Thromb Haemost. 2022 Dec;20(12):2786-2796. doi: 10.1111/jth.15888. Epub 2022 Oct 5. J Thromb Haemost. 2022. PMID: 36128757 Free PMC article.
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.
Gigante E, Hobeika C, Le Bail B, Paradis V, Tougeron D, Lequoy M, Bouattour M, Blanc JF, Ganne-Carrié N, Tran H, Hollande C, Allaire M, Amaddeo G, Regnault H, Vigneron P, Ronot M, Elkrief L, Verset G, Trepo E, Zaanan A, Ziol M, Ningarhari M, Calderaro J, Edeline J, Nault JC. Gigante E, et al. Liver Cancer. 2022 Jun 14;11(5):460-473. doi: 10.1159/000525488. eCollection 2022 Sep. Liver Cancer. 2022. PMID: 36158591 Free PMC article.
Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion.
Blaise L, Pereira H, Vilgrain V, Sutter O, Gigante E, Walter A, Ganne-Carrié N, Nahon P, Bouattour M, Dioguardi Burgio M, Grando V, Nkontchou G, Seror O, Nault JC. Blaise L, et al. Among authors: gigante e. Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101731. doi: 10.1016/j.clinre.2021.101731. Epub 2021 Jun 15. Clin Res Hepatol Gastroenterol. 2021. PMID: 34139320 Clinical Trial.
Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization.
Roth G, Teyssier Y, Benhamou M, Abousalihac M, Caruso S, Sengel C, Seror O, Ghelfi J, Seigneurin A, Ganne-Carrie N, Gigante E, Blaise L, Sutter O, Decaens T, Nault JC. Roth G, et al. Among authors: gigante e. World J Gastroenterol. 2022 Sep 28;28(36):5324-5337. doi: 10.3748/wjg.v28.i36.5324. World J Gastroenterol. 2022. PMID: 36185630 Free PMC article.
26 results